(Updated - December 21, 2021 4:24 AM EST)

KeyBanc analyst Matthew Mishan upgraded ResMed (NYSE: RMD) from Sector Weight ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE